Taming 2,2'-biimidazole ligands in trivalent chromium complexes.

Julien Chong, Amina Benchohra, Céline Besnard, Laure Guénée, Arnulf Rosspeintner, Carlos M Cruz, Juan-Ramón Jiménez, Claude Piguet

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Dalton transactions (Cambridge, England : 2003), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Heteroleptic [CrMolecules (Basel, Switzerland) · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Julien ChongDepartment of Inorganic and Analytical Chemistry, University of Geneva, 30 quai E. Ansermet, CH-1211 Geneva 4, Switzerland. Claude.Piguet@unige.ch.

Amina BenchohraDepartment of Inorganic and Analytical Chemistry, University of Geneva, 30 quai E. Ansermet, CH-1211 Geneva 4, Switzerland. Claude.Piguet@unige.ch.ORCID http://orcid.org/0000-0002-6060-6894

Céline BesnardLaboratory of Crystallography, University of Geneva, 24 quai E. Ansermet, CH-1211 Geneva 4, Switzerland.ORCID http://orcid.org/0000-0001-5699-9675

Laure GuénéeLaboratory of Crystallography, University of Geneva, 24 quai E. Ansermet, CH-1211 Geneva 4, Switzerland.

Arnulf RosspeintnerDepartment of Physical Chemistry, University of Geneva, 30 quai E. Ansermet, CH-1211 Geneva 4, Switzerland.ORCID http://orcid.org/0000-0002-1828-5206

Carlos M CruzDepartment of Organic Chemistry, Unidad de Excelencia de Química (UEQ), University of Granada, Avda. Fuente Nueva s/n, 18071 Granada, Spain.ORCID http://orcid.org/0000-0002-0676-5210

Juan-Ramón JiménezDepartamento de Química Inorgánica, Facultad de Ciencias, Universidad de Granada and Unidad de Excelencia en Quımica (UEQ), Avda. Fuente Nueva s/n, 18071 Granada, Spain.ORCID http://orcid.org/0000-0003-3871-3594

Claude PiguetDepartment of Inorganic and Analytical Chemistry, University of Geneva, 30 quai E. Ansermet, CH-1211 Geneva 4, Switzerland. Claude.Piguet@unige.ch.ORCID http://orcid.org/0000-0001-7064-8548

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complete or partial replacement of well-known five-membered chelating 2,2'-bipyridine (bipy) or 1,10-phenanthroline (phen) ligands with analogous didentate 2,2'-biimidazole (H

Identifiers

PMID39011611

DOI10.1039/d4dt01608d

PMCPMC11443315

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.